Level D· Scientific groundwork from lab and animal studiesAnimal StudyEurope PMCOpen access

Human umbilical cord mesenchymal stem cell delivery of mitochondria to melanocytes enhances skin repigmentation efficacy in autologous epidermal cell suspension transplantation through the TNFAIP2-TNT system

Jin X., Xiong S., Wang B., Wang Q., Zhang J., Wang Z.

Animal Study on Chronic Wound, published in Int J Biol Sci (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Int J Biol Sci (2026)
Reported sample size
—
Source database
Europe PMC
PMID
41694594
PMCID
PMC12905636
DOI
10.7150/ijbs.128719

Abstract (original English)

Autologous epidermal cell suspension (AECS) transplantation is essential for treating large-area depigmenting diseases and some chronic wounds that are refractory to conservative therapy. However, this technique encounters challenges, including limited repigmentation efficacy and high costs, which have hindered its clinical adoption. To enhance the repigmentation efficacy of AECS, our research explored the optimal conditions for preparing suspensions of epidermal cells (ECs). Next, we investigated the functions of melanocytes (MCs) and repigmentation efficacy through co-culturing and co-transplantation of human umbilical cord mesenchymal stem cells (hUCMSCs) with AECS. The addition of hUCMSCs to this system enhanced the proliferation, migration, and melanin synthesis capabilities of the ECs. These findings were validated in vivo , with the hUCMSCs co-transplantation group demonstrating superior skin repigmentation efficacy in mice. Then gene interference, overexpression, and transcriptome analyses were conducted to elucidate the mechanisms underlying the Tumor Necrosis Factor Alpha-Induced Protein 2 (TNFAIP2)-Tunneling Nanotubes (TNTs) system in mediating melanin synthesis. Our findings outline a novel pathway through which hUCMSCs, via the TNFAIP2-TNT system, mediate the delivery of mitochondria to melanocytes, enhancing the function of MCs. This presents new avenues for impro

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
MitochondriaMelanocytesMesenchymal Stem CellsUmbilical CordAnimalsHumansMiceMelaninsSkin PigmentationMesenchymal Stem Cell Transplantation

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research